© 2026
A Service of UA Little Rock
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Broadcast Notice: We’re moving equipment to our new studio location, which may cause occasional interruptions on KUAR 89.1 and KLRE Classical 90.5. We appreciate your patience as we complete this important transition.

Moderna and Merck's mRNA vaccine reduces melanoma recurrence by 42%

WBUR
Published October 27, 2026 at 11:01 AM CDT

Moderna and Merck recently released remarkable new results of their personalized cancer vaccine.

Here & Now‘s Scott Tong speaks with Matthew Herper, a senior writer at STAT, the health and science publication.

This article was originally published on WBUR.org.

Copyright 2026 WBUR